Ptc Therapeutics, Inc. financial data

Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Warren Corporate Center Drive, Warren, NJ
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 188 % +35.8%
Quick Ratio 5.62 % +2.93%
Debt-to-equity -304 % +37.5%
Return On Assets -28 % +29.6%
Operating Margin -22 % +69.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.9M shares +2.1%
Common Stock, Shares, Outstanding 76.9M shares +2.1%
Entity Public Float 2.33B USD +9.44%
Common Stock, Value, Issued 76K USD +1.33%
Weighted Average Number of Shares Outstanding, Basic 76.7M shares +2.67%
Weighted Average Number of Shares Outstanding, Diluted 76.7M shares +2.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 900M USD +9.98%
Research and Development Expense 534M USD -27.4%
Operating Income (Loss) -198M USD +66.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -494M USD +28.3%
Income Tax Expense (Benefit) -14.6M USD +79.6%
Net Income (Loss) Attributable to Parent -480M USD +22.4%
Earnings Per Share, Basic -6.32 USD/shares +24.9%
Earnings Per Share, Diluted -6.32 USD/shares +24.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 655M USD +214%
Marketable Securities, Current 439M USD +238%
Inventory, Net 31.8M USD -0.6%
Assets, Current 1.36B USD +130%
Property, Plant and Equipment, Net 66M USD -19.7%
Operating Lease, Right-of-Use Asset 57.1M USD -40.9%
Intangible Assets, Net (Excluding Goodwill) 330M USD -27%
Goodwill 82.3M USD 0%
Assets 1.92B USD +43.2%
Accounts Payable, Current 24.3M USD -5.68%
Employee-related Liabilities, Current 36.7M USD -24.6%
Contract with Customer, Liability, Current 801K USD -40.7%
Liabilities, Current 610M USD +28%
Deferred Income Tax Liabilities, Net 55.9M USD +7.67%
Operating Lease, Liability, Noncurrent 79.1M USD -21.2%
Other Liabilities, Noncurrent 141K USD 0%
Liabilities 2.9B USD +51.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16.5M USD -1053%
Retained Earnings (Accumulated Deficit) -3.47B USD -16%
Stockholders' Equity Attributable to Parent -980M USD -69.2%
Liabilities and Equity 1.92B USD +43.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 70.8M USD
Net Cash Provided by (Used in) Financing Activities 540K USD -86.8%
Net Cash Provided by (Used in) Investing Activities -115M USD -297%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 76.9M shares +2.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.7M USD +26.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 669M USD +198%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.67M USD -71.7%
Deferred Tax Assets, Valuation Allowance 834M USD +24%
Deferred Tax Assets, Gross 841M USD +24.3%
Operating Lease, Liability 92.8M USD -16.1%
Payments to Acquire Property, Plant, and Equipment 9.59M USD -6.64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -495M USD +21.5%
Lessee, Operating Lease, Liability, to be Paid 190M USD -27.2%
Property, Plant and Equipment, Gross 138M USD +25.8%
Operating Lease, Liability, Current 13.7M USD +34.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.6M USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.2M USD -12%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.6%
Deferred Income Tax Expense (Benefit) -1K USD +75%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 97.6M USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.4M USD -32.9%
Unrecognized Tax Benefits 1.36M USD -95%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.9M USD -10.2%
Operating Lease, Payments 3.95M USD +3.6%
Additional Paid in Capital 2.51B USD +3.88%
Amortization of Intangible Assets 190M USD +23.8%
Depreciation, Depletion and Amortization 55.4M USD +29.4%
Deferred Tax Assets, Net of Valuation Allowance 7.48M USD +66.8%
Share-based Payment Arrangement, Expense 81.1M USD -29%